To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Biomarker Development Strategies
ExL Pharma have announced that their Biomarker Development Strategies conference will be held at the Omni Shoreham Hotel in
Washington, DC, January 29-30, 2007
EVENT HIGHLIGHTS
• Hear directly from the FDA about the new regulatory framework for biomarkers
• Hear case studies and real world examples from Novartis, Eli Lilly, Amgen, Bristol Myer
Squibb, Centocor/J&J, Wyeth and National Cancer Institute
• Discover the Role of Collaborations & Consortia in Biomarker advancement
• Advances in the use of Proteomics, Metabolomics and Nanotechnology for Biomarker-
Based Drug Development
• Applications of Biomarkers in Early Phase Studies
• Using Biomarkers for Oncology Clinical Development
Faculty includes:
Alfred Ajami, CSO, Xanthus Pharmceuticals
Felix Frueh, Associate Director Genomics, FDA
Michael Shi, Director of Biomarker Development, Novartis
Register Today! Call 866-207-6529 or visit us at www.exlpharma.com
